BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28756021)

  • 1. Association of clinical severity of cystic fibrosis with variants in the SLC gene family (SLC6A14, SLC26A9, SLC11A1 and SLC9A3).
    Pereira SV; Ribeiro JD; Bertuzzo CS; Marson FAL
    Gene; 2017 Sep; 629():117-126. PubMed ID: 28756021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction among variants in the SLC gene family (SLC6A14, SLC26A9, SLC11A1, and SLC9A3) and CFTR mutations with clinical markers of cystic fibrosis.
    Pereira SVN; Ribeiro JD; Bertuzzo CS; Marson FAL
    Pediatr Pulmonol; 2018 Jul; 53(7):888-900. PubMed ID: 29635781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities.
    Li W; Soave D; Miller MR; Keenan K; Lin F; Gong J; Chiang T; Stephenson AL; Durie P; Rommens J; Sun L; Strug LJ
    Hum Genet; 2014 Feb; 133(2):151-61. PubMed ID: 24057835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent of rescue of F508del-CFTR function by VX-809 and VX-770 in human nasal epithelial cells correlates with SNP rs7512462 in SLC26A9 gene in F508del/F508del Cystic Fibrosis patients.
    Kmit A; Marson FAL; Pereira SV; Vinagre AM; Leite GS; Servidoni MF; Ribeiro JD; Ribeiro AF; Bertuzzo CS; Amaral MD
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1323-1331. PubMed ID: 30716472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
    Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
    Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variants in Solute Carrier SLC26A9 Modify Prenatal Exocrine Pancreatic Damage in Cystic Fibrosis.
    Miller MR; Soave D; Li W; Gong J; Pace RG; Boëlle PY; Cutting GR; Drumm ML; Knowles MR; Sun L; Rommens JM; Accurso F; Durie PR; Corvol H; Levy H; Sontag MK; Strug LJ
    J Pediatr; 2015 May; 166(5):1152-1157.e6. PubMed ID: 25771386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variants in the interleukin 8 gene and the response to inhaled bronchodilators in cystic fibrosis.
    Furlan LL; Ribeiro JD; Bertuzzo CS; Salomão Junior JB; Souza DRS; Marson FAL
    J Pediatr (Rio J); 2017; 93(6):639-648. PubMed ID: 28719800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of pancreatic status, CFTR mutations, Staphylococcus aureus and/or Pseudomonas aeruginosa infection/colonization on lung function in cystic fibrosis during a 2-year follow-up period.
    Pascoal MA; Marson FAL; Paschoal IA; Levy CE
    Wien Klin Wochenschr; 2020 Oct; 132(19-20):572-580. PubMed ID: 32356101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in ADRB2 gene can modulate the response to bronchodilators and the severity of cystic fibrosis.
    Marson FA; Bertuzzo CS; Ribeiro AF; Ribeiro JD
    BMC Pulm Med; 2012 Sep; 12():50. PubMed ID: 22950544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of common haplotypes of surfactant protein A1 and A2 (SFTPA1 and SFTPA2) genes with severity of lung disease in cystic fibrosis.
    Choi EH; Ehrmantraut M; Foster CB; Moss J; Chanock SJ
    Pediatr Pulmonol; 2006 Mar; 41(3):255-62. PubMed ID: 16429424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in the glutathione pathway modulate cystic fibrosis severity: a cross-sectional study.
    Marson FA; Bertuzzo CS; Ribeiro AF; Ribeiro JD
    BMC Med Genet; 2014 Mar; 15():27. PubMed ID: 24593045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis.
    Sun L; Rommens JM; Corvol H; Li W; Li X; Chiang TA; Lin F; Dorfman R; Busson PF; Parekh RV; Zelenika D; Blackman SM; Corey M; Doshi VK; Henderson L; Naughton KM; O'Neal WK; Pace RG; Stonebraker JR; Wood SD; Wright FA; Zielenski J; Clement A; Drumm ML; Boëlle PY; Cutting GR; Knowles MR; Durie PR; Strug LJ
    Nat Genet; 2012 May; 44(5):562-9. PubMed ID: 22466613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL8 gene as modifier of cystic fibrosis: unraveling the factors which influence clinical variability.
    Furlan LL; Marson FA; Ribeiro JD; Bertuzzo CS; Salomão Junior JB; Souza DR
    Hum Genet; 2016 Aug; 135(8):881-94. PubMed ID: 27209008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial concordance of phenotype and microbial variation among siblings with CF.
    Picard E; Aviram M; Yahav Y; Rivlin J; Blau H; Bentur L; Avital A; Villa Y; Schwartz S; Kerem B; Kerem E
    Pediatr Pulmonol; 2004 Oct; 38(4):292-7. PubMed ID: 15334505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulatory effect of the SLC9A3 gene on susceptibility to infections and pulmonary function in children with cystic fibrosis.
    Dorfman R; Taylor C; Lin F; Sun L; Sandford A; Paré P; Berthiaume Y; Corey M; Durie P; Zielenski J;
    Pediatr Pulmonol; 2011 Apr; 46(4):385-92. PubMed ID: 20967843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mannose-binding lectin gene as a modifier of the cystic fibrosis phenotype in Argentinean pediatric patients.
    Gravina LP; Crespo C; Giugno H; Sen L; Chertkoff L; Mangano A; Castaños C
    J Cyst Fibros; 2015 Jan; 14(1):78-83. PubMed ID: 25178872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of improved pulmonary phenotype in Irish cystic fibrosis patients with a 3' enhancer polymorphism in alpha-1-antitrypsin.
    Courtney JM; Plant BJ; Morgan K; Rendall J; Gallagher C; Ennis M; Kalsheker N; Elborn S; O'Connor CM
    Pediatr Pulmonol; 2006 Jun; 41(6):584-91. PubMed ID: 16617455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic modifiers of lung disease in cystic fibrosis.
    Drumm ML; Konstan MW; Schluchter MD; Handler A; Pace R; Zou F; Zariwala M; Fargo D; Xu A; Dunn JM; Darrah RJ; Dorfman R; Sandford AJ; Corey M; Zielenski J; Durie P; Goddard K; Yankaskas JR; Wright FA; Knowles MR;
    N Engl J Med; 2005 Oct; 353(14):1443-53. PubMed ID: 16207846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SLC6A14 Impacts Cystic Fibrosis Lung Disease Severity
    Mercier J; Calmel C; Mésinèle J; Sutanto E; Merabtene F; Longchampt E; Sage E; Kicic A; Boëlle PY; Corvol H; Ruffin M; Guillot L
    Front Mol Biosci; 2022; 9():850261. PubMed ID: 35372502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genetic background of osteoporosis in cystic fibrosis: association analysis with polymorphic markers in four candidate genes.
    Castellani C; Malerba G; Sangalli A; Delmarco A; Petrelli E; Rossini M; Assael BM; Mottes M
    J Cyst Fibros; 2006 Dec; 5(4):229-35. PubMed ID: 16713399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.